Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

This Phase 2 trial update assesses the pharmacokinetics, safety, and efficacy of two doses of bimekizumab in adolescents with moderate to severe plaque psoriasi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate to Severe Plaque Psoriasis | Phase 2 | Status: COMPLETED